139 related articles for article (PubMed ID: 23726144)
1. Integrative analysis of copy number alteration and gene expression profiling in ovarian clear cell adenocarcinoma.
Sung CO; Choi CH; Ko YH; Ju H; Choi YL; Kim N; Kang SY; Ha SY; Choi K; Bae DS; Lee JW; Kim TJ; Song SY; Kim BG
Cancer Genet; 2013 May; 206(5):145-53. PubMed ID: 23726144
[TBL] [Abstract][Full Text] [Related]
2. Somatic copy number alterations have prognostic impact in patients with ovarian clear cell carcinoma.
Morikawa A; Hayashi T; Kobayashi M; Kato Y; Shirahige K; Itoh T; Urashima M; Okamoto A; Akiyama T
Oncol Rep; 2018 Jul; 40(1):309-318. PubMed ID: 29749539
[TBL] [Abstract][Full Text] [Related]
3. High-resolution gene copy number and expression profiling of human chromosome 22 in ovarian carcinomas.
Benetkiewicz M; Wang Y; Schaner M; Wang P; Mantripragada KK; Buckley PG; Kristensen G; Børresen-Dale AL; Dumanski JP
Genes Chromosomes Cancer; 2005 Mar; 42(3):228-37. PubMed ID: 15578687
[TBL] [Abstract][Full Text] [Related]
4. Identification of DNA copy number changes in microdissected serous ovarian cancer tissue using a cDNA microarray platform.
Tsuda H; Birrer MJ; Ito YM; Ohashi Y; Lin M; Lee C; Wong WH; Rao PH; Lau CC; Berkowitz RS; Wong KK; Mok SC
Cancer Genet Cytogenet; 2004 Dec; 155(2):97-107. PubMed ID: 15571795
[TBL] [Abstract][Full Text] [Related]
5. High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization.
Naylor TL; Greshock J; Wang Y; Colligon T; Yu QC; Clemmer V; Zaks TZ; Weber BL
Breast Cancer Res; 2005; 7(6):R1186-98. PubMed ID: 16457699
[TBL] [Abstract][Full Text] [Related]
6. Clinical implications of gene dosage and gene expression patterns in diploid breast carcinoma.
Parris TZ; Danielsson A; Nemes S; Kovács A; Delle U; Fallenius G; Möllerström E; Karlsson P; Helou K
Clin Cancer Res; 2010 Aug; 16(15):3860-74. PubMed ID: 20551037
[TBL] [Abstract][Full Text] [Related]
7. Integrated analysis of copy number and loss of heterozygosity in primary breast carcinomas using high-density SNP array.
Ching HC; Naidu R; Seong MK; Har YC; Taib NA
Int J Oncol; 2011 Sep; 39(3):621-33. PubMed ID: 21687935
[TBL] [Abstract][Full Text] [Related]
8. LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization.
Kresse SH; Ohnstad HO; Paulsen EB; Bjerkehagen B; Szuhai K; Serra M; Schaefer KL; Myklebost O; Meza-Zepeda LA
Genes Chromosomes Cancer; 2009 Aug; 48(8):679-93. PubMed ID: 19441093
[TBL] [Abstract][Full Text] [Related]
9. Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients.
Horlings HM; Lai C; Nuyten DS; Halfwerk H; Kristel P; van Beers E; Joosse SA; Klijn C; Nederlof PM; Reinders MJ; Wessels LF; van de Vijver MJ
Clin Cancer Res; 2010 Jan; 16(2):651-63. PubMed ID: 20068109
[TBL] [Abstract][Full Text] [Related]
10. Genomic alterations of chromosome region 11p as predictive marker by array comparative genomic hybridization in lung adenocarcinoma patients.
Sung JS; Park KH; Kim YH
Cancer Genet Cytogenet; 2010 Apr; 198(1):27-34. PubMed ID: 20303011
[TBL] [Abstract][Full Text] [Related]
11. Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma.
Schraml P; Schwerdtfeger G; Burkhalter F; Raggi A; Schmidt D; Ruffalo T; King W; Wilber K; Mihatsch MJ; Moch H
Am J Pathol; 2003 Sep; 163(3):985-92. PubMed ID: 12937139
[TBL] [Abstract][Full Text] [Related]
12. A systematic comparison of copy number alterations in four types of female cancer.
Kaveh F; Baumbusch LO; Nebdal D; Børresen-Dale AL; Lingjærde OC; Edvardsen H; Kristensen VN; Solvang HK
BMC Cancer; 2016 Nov; 16(1):913. PubMed ID: 27876019
[TBL] [Abstract][Full Text] [Related]
13. Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor 1 as a prognostic marker for advanced-stage serous ovarian adenocarcinomas.
Birrer MJ; Johnson ME; Hao K; Wong KK; Park DC; Bell A; Welch WR; Berkowitz RS; Mok SC
J Clin Oncol; 2007 Jun; 25(16):2281-7. PubMed ID: 17538174
[TBL] [Abstract][Full Text] [Related]
14. DNA copy number alterations and expression of relevant genes in triple-negative breast cancer.
Han W; Jung EM; Cho J; Lee JW; Hwang KT; Yang SJ; Kang JJ; Bae JY; Jeon YK; Park IA; Nicolau M; Jeffrey SS; Noh DY
Genes Chromosomes Cancer; 2008 Jun; 47(6):490-9. PubMed ID: 18314908
[TBL] [Abstract][Full Text] [Related]
15. DNA copy numbers profiles in affinity-purified ovarian clear cell carcinoma.
Kuo KT; Mao TL; Chen X; Feng Y; Nakayama K; Wang Y; Glas R; Ma MJ; Kurman RJ; Shih IeM; Wang TL
Clin Cancer Res; 2010 Apr; 16(7):1997-2008. PubMed ID: 20233889
[TBL] [Abstract][Full Text] [Related]
16. High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma.
Yoshimoto T; Matsuura K; Karnan S; Tagawa H; Nakada C; Tanigawa M; Tsukamoto Y; Uchida T; Kashima K; Akizuki S; Takeuchi I; Sato F; Mimata H; Seto M; Moriyama M
J Pathol; 2007 Dec; 213(4):392-401. PubMed ID: 17922474
[TBL] [Abstract][Full Text] [Related]
17. Genetic aberrations in prostate cancer by microarray analysis.
Saramäki OR; Porkka KP; Vessella RL; Visakorpi T
Int J Cancer; 2006 Sep; 119(6):1322-9. PubMed ID: 16642477
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer.
Tsukamoto Y; Uchida T; Karnan S; Noguchi T; Nguyen LT; Tanigawa M; Takeuchi I; Matsuura K; Hijiya N; Nakada C; Kishida T; Kawahara K; Ito H; Murakami K; Fujioka T; Seto M; Moriyama M
J Pathol; 2008 Dec; 216(4):471-82. PubMed ID: 18798223
[TBL] [Abstract][Full Text] [Related]
19. Genomic change of chromosome 8 predicts the response to taxane-based neoadjuvant chemotherapy in node-positive breast cancer.
Han S; Park K; Shin E; Kim HJ; Kim JY; Kim JY; Gwak G
Oncol Rep; 2010 Jul; 24(1):121-8. PubMed ID: 20514452
[TBL] [Abstract][Full Text] [Related]
20. High-resolution array comparative genomic hybridization of chromosome arm 8q: evaluation of genetic progression markers for prostate cancer.
van Duin M; van Marion R; Vissers K; Watson JE; van Weerden WM; Schröder FH; Hop WC; van der Kwast TH; Collins C; van Dekken H
Genes Chromosomes Cancer; 2005 Dec; 44(4):438-49. PubMed ID: 16130124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
